Global Japanese Encephalitis Market is expected to reach US$ 7.33 Bn. at a CAGR of 5.9 during the forecast period 2026.Global Japanese Encephalitis Market Overview:
Japanese encephalitis is a virus spread by mosquitos. The Japanese encephalitis virus causes a brain infection known as Japanese encephalitis (JE). Brain inflammation does occur on occasion. Other symptoms include headaches, vomiting, fever, confusion, and seizures in these cases.Global Japanese Encephalitis Market Dynamics:
Rising prevalence of viral encephalitis is the major factor driving the market growth.
The growth of this market is due to the rising prevalence of Japanese encephalitis diseases around the world. The market is driven by an increase in cases of mosquito-borne flavivirus diseases. It is caused by a flavivirus spread by mosquitos, which belongs to the same family as yellow fever, dengue fever, and West Nile viruses. The virus is present in pigs and birds, and it is spread to humans by mosquito bites from infected Culex species. Furthermore, increased understanding of Japanese encephalitis vaccination by WHO and government officials, as well as an increase in the incidence of yellow fever, dengue, and West Nile viruses are expected to boost the market growth. The World Health Organization states that, JE affects about 68000 people worldwide in a year. During the forecast era, one of the major growth drivers for the market will be the inclusion of vaccination against Japanese encephalitis in national immunization plans. During the forecast period, factors such as stringent government regulation regarding efficacy and safety, lack of knowledge and lack of vaccine supply in remote areas may be the major restraining factors for the global Japanese encephalitis vaccine market. The report has profiled fifteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.Global Japanese Encephalitis Market Segment Analysis:
The Global Japanese Encephalitis Market is segmented on the basis of diagnosis and Vaccine Type,
Based on diagnosis, the IgM Capture ELISA test segment is expected to dominate the global market during the forecast period. IgM antibodies to the JE virus are normally detectable 3 to 8 days after the onset of illness and last 30 to 90 days, though longer persistence has been recorded. As a result, positive IgM antibodies can sometimes indicate a previous infection or vaccination. Based on Vaccine Type, Inactivated Vero-cell derived vaccine segment is expected to account for the largest share during the forecast period. Since mouse brain-derived vaccines are being replaced by cell-based vaccines due to higher effectiveness, safety, and animal ethical regulations, the Vero cell-derived vaccine segment is expected to account for a XX% share of the market during the forecast period. There are approximately seven vaccines approved, which contributes to the dominant market share held by inactivated vaccines. This is due to the growing number of inactivated vaccine options available and their high efficacy in treating the indication.To know about the Research Methodology :- Request Free Sample Report
Global Japanese Encephalitis Market Regional Insights:
Asia Pacific is expected to hold the largest the market share during forecast period.
Due to the high prevalence of JE, government-mandated immunization programmes, increasing investment in R&D, entry of new vaccine manufacturers in countries such as India and China, increased number of travellers in the area, medical tourism, and other factors, The Asia Pacific is anticipated to be the most lucrative market. Vaccination is a key component of UNICEF, WHO, and Gavi's efforts to stop the disease from spreading. The addition of vaccination against Japanese encephalitis to India's Universal Immunization Program in 2014 resulted in a substantial increase in vaccination does procurement. In other Asian countries, such initiatives are becoming more popular. The report also helps in understanding Global Japanese Encephalitis Market dynamics, structure by analyzing the market segments and project the Global Japanese Encephalitis Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Japanese Encephalitis Market make the report investor’s guide.Global Japanese Encephalitis Market Scope: Inquire before buying
Global Japanese Encephalitis Market, By Region:
• North America • Europe • South America • MEA • APACGlobal Japanese Encephalitis Market, Key players:
• GSK • Bharat Biotech • Wuhan Institute of Biological • Sanofi • Valneva • Chengdu institute of biologica • Liaoning Chengda • Beijing Taitan • Lanzhou Institute of Biological • Biological E. Limited • Intercell Biomedical Ltd. • Novartis International AG • Green Cross Corp. • BIKEN • China National Pharmaceutical Group
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Japanese Encephalitis Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Japanese Encephalitis Market 3.4. Geographical Snapshot of the Japanese Encephalitis Market, By Manufacturer share 4. Global Japanese Encephalitis Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Japanese Encephalitis Market 5. Supply Side and Demand Side Indicators 6. Global Japanese Encephalitis Market Analysis and Forecast, 2019-2026 6.1. Global Japanese Encephalitis Market Size & Y-o-Y Growth Analysis. 7. Global Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 7.1.1. Blood Test 7.1.2. IgM-Capture ELISA 7.1.3. Cerebrospinal Fluid Test 7.1.4. Others 7.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 7.2.1. Mouse brain derived vaccine 7.2.2. Live attenuated vaccine 7.2.3. Live recombinant vaccine 7.2.4. Inactivated Vero-cell derived vaccine 8. Global Japanese Encephalitis Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 9.1.1. Blood Test 9.1.2. IgM-Capture ELISA 9.1.3. Cerebrospinal Fluid Test 9.1.4. Others 9.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 9.2.1. Mouse brain derived vaccine 9.2.2. Live attenuated vaccine 9.2.3. Live recombinant vaccine 9.2.4. Inactivated Vero-cell derived vaccine 10. North America Japanese Encephalitis Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 12. Canada Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 13. Mexico Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 14. Europe Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 15. Europe Japanese Encephalitis Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 17. France Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 18. Germany Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 19. Italy Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 20. Spain Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 21. Sweden Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 22. CIS Countries Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 23. Rest of Europe Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 24. Asia Pacific Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 25. Asia Pacific Japanese Encephalitis Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 27. India Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 28. Japan Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 29. South Korea Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 30. Australia Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 31. ASEAN Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 32. Rest of Asia Pacific Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 33. Middle East Africa Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 34. Middle East Africa Japanese Encephalitis Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 36. GCC Countries Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 37. Egypt Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 38. Nigeria Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 39. Rest of ME&A Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 40. South America Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 41. South America Japanese Encephalitis Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 43. Argentina Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 44. Rest of South America Japanese Encephalitis Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Diagnosis, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Japanese Encephalitis Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. GSK 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Bharat Biotech 45.3.3. Wuhan Institute of Biological 45.3.4. Sanofi 45.3.5. Valneva 45.3.6. Chengdu institute of biologica 45.3.7. Liaoning Chengda 45.3.8. Beijing Taitan 45.3.9. Lanzhou Institute of Biological 45.3.10. Biological E. Limited 45.3.11. Intercell Biomedical Ltd. 45.3.12. Novartis International AG 45.3.13. Green Cross Corp. 45.3.14. BIKEN 45.3.15. China National Pharmaceutical Group 46. Primary Key Insights